The domestic brand won the bid for the PTCA guide wire coronary artery device as the first place in the first group

Following the implementation of the collection of coronary stents and coronary balloons, various provinces and cities have actively carried out the procurement of coronary guide wires

1

The results of the bid-winning purchase of this equipment have been announced

On August 3, the Inner Mongolia Medical Insurance Bureau issued an announcement on the results of the Procurement Office of the Inter-provincial Union on the Selection of the Concentrated Procurement of Coronary Guide Wires.

According to the results of the centralized procurement declaration information disclosure conference held a few days ago, the total number of coronary guide wires for the intention to purchase this time was 362,422.

Public information shows that the coronary guide wire is a necessary medical consumable in coronary interventional therapy, and it is one of the most difficult products in coronary interventional technology

Since December last year, coronary stents and coronary balloons have been purchased in quantities

It is understood that the products that have won the bid will begin in September this year in 13 provinces including Heilongjiang, Inner Mongolia, Shanxi, Liaoning, Jilin, Hainan, Guizhou, Tibet, Gansu, Qinghai, Ningxia, Xinjiang, and Xinjiang Production and Construction Corps.

2

The price is cut by nearly two-thirds

In July 2019, the General Office of the State Council issued the "Notice on Issuing the Reform Plan for Governance of High-Value Medical Consumables", requiring high-value medical consumables produced by multiple companies with large clinical usage, high purchase amount, mature clinical use , Explore centralized procurement by category, encourage medical institutions to jointly carry out procurement through negotiation, and actively explore inter-provincial alliance procurement

At present, the number of domestic coronary heart disease cases is growing rapidly, and the number of cases nationwide exceeds one million.

And before the collection, the price of the product has been high, which is a big burden for patients, medical insurance funds, or hospitals

Therefore, with the implementation of the procurement of coronary stents and coronary balloons, the coronary guide wire has gradually begun to be purchased.

This time, the provincial alliance did not disappoint the expectations.

3

Central procurement of consumables, domestic brands won the bid again

The essence of volume procurement is to reduce costs and increase efficiency, and also to solve people's livelihood problems

However, the technical threshold of coronary guide wire is much higher than that of coronary stents.

Take the top-ranked Shunmei Medical as an example.

It is understood that Shunmei Medical’s main products are various vascular interventional and anesthesia consumables.

From the perspective of R&D, its product development is closely integrated with clinical needs.

In terms of production capacity assurance, Shunmei Medical relies on its own production base of 30 acres in Huizhou, coupled with years of large-scale production experience and a sound production management system, the production value of Shunmei Medical can reach hundreds of millions of yuan each year
.

In addition, Shunmei Medical's sales network has covered domestic and foreign markets, and wholly-owned sales subsidiaries have been established in Germany, Poland, Turkey, Egypt, and India.
In recent years, its international business has maintained sustained rapid growth
.
The new products can be seamlessly connected from getting the certificate to the market
.
With strong product transformation capabilities, it has established a rapid response and rapid implementation R&D system from project establishment, R&D, type inspection, clinical, registration, and listing
.

Of course, this may also be important for Shunmei Medical to participate in the bidding under the general environment of centralized procurement this year, and finally enter the centralized procurement catalog of multiple provinces
.
And once this step is taken, Shunmei Medical's revenue and profits will usher in explosive growth
.